Brief: Memphasys Seeks Trading Halt
19/03/2025 22:18
March 20 (Reuters) - Memphasys Ltd MEM.AX: SEEKS TRADING HALT PENDING ANNOUNCEMENT ON FELIX SYSTEM CLINICAL TRIAL RESULTS Further company coverage: MEM.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Memphasys
See all newsBrief: Memphasys Receives A$3.5 Million From Peters Investments
Brief: Memphasys Says Potential Expedited FDA Pathway To US IVF Market
Brief: Memphasys Secures 3-Year Felix Agreement With Invido For A$674,000 Minimum Purchases
Australia's Memphasys soars on signing exclusive commercialisation agreement with NOVIVITAE
Brief: Memphasys Says Vietnamese Registration For Felix System Has Been Achieved In August 2026